Literature DB >> 6842606

Coenzyme binding in crystals of glyceraldehyde-3-phosphate dehydrogenase.

A G Leslie, A J Wonacott.   

Abstract

Apo-glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus and the partially saturated holo-enzyme can be crystallized isomorphously with the entire tetramer occupying the crystal asymmetric unit. For crystals that contain one molecule of NAD+ per tetramer the coenzyme is bound uniquely in one of the four available sites. The presence of NAD+ gives rise to nonequivalence in the binding of a heavy-atom compound to the subunits of the tetramer while for the apo-enzyme this binding is clearly symmetric. These results suggest that NAD binding gives rise to sequential ligand-induced structural changes of the tetramer, which may be responsible for the observed negative cooperativity in coenzyme binding.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6842606     DOI: 10.1016/s0022-2836(83)80262-9

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  4 in total

Review 1.  Towards the engineering of in vitro systems.

Authors:  Christoph Hold; Sven Panke
Journal:  J R Soc Interface       Date:  2009-05-27       Impact factor: 4.118

2.  Cloning, molecular characterization, and functional activity of Schistosoma japonicum glyceraldehyde-3-phosphate dehydrogenase, a putative vaccine candidate against schistosomiasis japonica.

Authors:  G J Waine; M Becker; W Yang; B Kalinna; D P McManus
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

3.  The major parasite surface antigen associated with human resistance to schistosomiasis is a 37-kD glyceraldehyde-3P-dehydrogenase.

Authors:  V Goudot-Crozel; D Caillol; M Djabali; A J Dessein
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

4.  Pattern recognition techniques applied to the study of leishmanial glyceraldehyde-3-phosphate dehydrogenase inhibition.

Authors:  Norka B H Lozano; Rafael F Oliveira; Karen C Weber; Kathia M Honorio; Rafael V C Guido; Adriano D Andricopulo; Alexsandro G de Sousa; Albérico B F da Silva
Journal:  Int J Mol Sci       Date:  2014-02-21       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.